Advanced Biomedical Technologies

Advanced Biomedical Technologies Financing Cash Flow

The Net Financing Cash Flow of Advanced Biomedical Technologies (ABMT) as of Nov 4, 2026 is 703,953.00 USD. In the previous year, Net Financing Cash Flow was 725,690.00 USD — a change of -3.00% (lower).

Financing Cash Flow

703,953.00USD

YoY

-3.00%

Last updated:

Net Financing Cash Flow of Advanced Biomedical Technologies is 2022 703,953.00 USD. Net Financing Cash Flow of Advanced Biomedical Technologies was 2021 725,690.00 USD. It decreases by -3.00% lower compared to the previous year.

The Advanced Biomedical Technologies Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2015
801,975.00 USD
Jan 1, 2016
343,826.00 USD
Jan 1, 2017
557,751.00 USD
Jan 1, 2018
896,280.00 USD
Jan 1, 2019
759,842.00 USD
Jan 1, 2020
-427,821.00 USD
Jan 1, 2021
725,690.00 USD
Jan 1, 2022
703,953.00 USD
The Advanced Biomedical Technologies Financing Cash Flow history
YEARFinancing Cash FlowYoY
703,953.00USD-3.00%
725,690.00USD-269.62%
-427,821.00USD-156.30%
759,842.00USD-15.22%
896,280.00USD+60.70%
557,751.00USD+62.22%
343,826.00USD-57.13%
801,975.00USD+2.52%
782,228.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Advanced Biomedical Technologies Stock analysis

What does Advanced Biomedical Technologies do? Advanced Biomedical Technologies Inc is an innovative biomedical company specializing in the development of advanced medical devices and technologies. The company was founded in 1985 by an experienced team of biotech experts and is headquartered in California, USA. History: The company's roots lie in the research and development of novel medical implants and prosthetics. However, over the years, the company has quickly evolved into a leading provider of medical devices and technologies in the fields of diagnostics, therapy, and care. Business model: The business model of Advanced Biomedical Technologies Inc is focused on providing innovative and advanced solutions for medical care. The company strives to continuously develop its products and help customers achieve their healthcare goals. Divisions: The company is divided into four main divisions focusing on different medical areas: 1) Interventional Cardiology: Here, the company develops devices for the treatment of heart diseases, such as stents for reopening narrowed vessels. 2) Orthopedics: Another focus is on the development of innovative orthopedic implants and prosthetics that help patients regain their mobility and improve their quality of life. 3) Oncology: In this division, the company works on the development of medical devices and systems for the diagnosis and treatment of cancer. 4) Neurology: Here, the company focuses on the development of medical technologies and devices for the diagnosis and treatment of nervous system disorders, such as Parkinson's or Alzheimer's. Products: Advanced Biomedical Technologies Inc's products include a variety of medical devices and technologies specialized in different medical areas. Some of the company's most well-known products are: - Stents for reopening narrowed vessels in the heart - Artificial joints and implants for restoring mobility and quality of life - Medical devices for the diagnosis and treatment of cancer - Neurostimulation devices for the treatment of chronic pain and other neurological disorders - Robot-assisted surgery systems that assist surgeons in complex procedures. Conclusion: Advanced Biomedical Technologies Inc is a leading biomedical company specializing in the development of advanced medical devices and technologies. The company has a long history in the research and development of medical implants and prosthetics but has quickly expanded into a broader range of medical applications. With its focus on developing innovative products for patients' quality of life, Advanced Biomedical Technologies Inc will continue to play an important role in medical innovation. Advanced Biomedical Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Advanced Biomedical Technologies stock

Net Financing Cash Flow of Advanced Biomedical Technologies is 703,953.00 USD in 2022.

Net Financing Cash Flow of Advanced Biomedical Technologies changed from 725,690.00 USD to 703,953.00 USD, representing a -3.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Advanced Biomedical Technologies since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Advanced Biomedical Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Advanced Biomedical Technologies

All Key Metrics — Advanced Biomedical Technologies